<DOC>
	<DOCNO>NCT00783250</DOCNO>
	<brief_summary>The aim study assess effect respiratory mechanic one `` classical '' short-term bronchodilator ( i.e. , salbutamol ) versus placebo , verify hypothesis addition another bronchodilator ( i.e. , anticholinergic ) may induce improvement work breathe stable COPD patient .</brief_summary>
	<brief_title>Bronchodilators Respiratory Mechanics Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description>Studies long-acting b2-agonists COPD patient poorly respond routine airway obstruction reversibility test force expiratory manoeuvre , force expiratory volume one second ( FEV1 ) , scarce . Such study , however , seem show favourable effect clinical parameter . This may explain subjective improvement change quality life long-acting b2-agonists patient COPD . The lack effect force expiration test may due early airway collapse subsequent airflow decline cause underestimation exist bronchodilatory effect locate peripherally respiratory tract , major site resistance locate obstructive lung disease . We therefore design study aim assess short term effect one short-acting beta2-agonist v placebo , effect additional sequential administration different bronchodilator , like tiotropium bromide ( anticholinergic agent ) work breathing , component ( i.e. , lung resistance compliance ) COPD patient poor reversibility assess use classical Pulmonary Function Tests .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>COPD patient Tiffenau ratio &lt; 55 % &gt; 25 % predict Poor reversibility acute bronchodilator test ( i.e . FEV1 change &lt; 10 % baseline ) Lack informed consent Cancer Concomitant lung airway disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>COPD</keyword>
	<keyword>Respiratory Mechanics</keyword>
	<keyword>Bronchodilators</keyword>
	<keyword>COPD patient poor reversibility</keyword>
</DOC>